BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 21748782)

  • 1. A majority of the cancer/testis antigens are intrinsically disordered proteins.
    Rajagopalan K; Mooney SM; Parekh N; Getzenberg RH; Kulkarni P
    J Cell Biochem; 2011 Nov; 112(11):3256-67. PubMed ID: 21748782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unusual aggregation property of recombinantly expressed cancer-testis antigens in mammalian cells.
    Ahmadi H; Shogen K; Fujita K; Honjo T; Kakimi K; Futami J
    J Biochem; 2021 Oct; 170(3):435-443. PubMed ID: 34247245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer/Testis Antigens: "Smart" Biomarkers for Diagnosis and Prognosis of Prostate and Other Cancers.
    Kulkarni P; Uversky VN
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28362316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derepression of Cancer/testis antigens in cancer is associated with distinct patterns of DNA hypomethylation.
    Kim R; Kulkarni P; Hannenhalli S
    BMC Cancer; 2013 Mar; 13():144. PubMed ID: 23522060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic cancer/testis antigens are a hallmarker of cancer and a sensible target for cancer immunotherapy.
    Yang P; Meng M; Zhou Q
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188558. PubMed ID: 33933558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
    Salmaninejad A; Zamani MR; Pourvahedi M; Golchehre Z; Hosseini Bereshneh A; Rezaei N
    Immunol Invest; 2016 Oct; 45(7):619-40. PubMed ID: 27603913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cancer/testis antigens in prostate cancer is associated with disease progression.
    Suyama T; Shiraishi T; Zeng Y; Yu W; Parekh N; Vessella RL; Luo J; Getzenberg RH; Kulkarni P
    Prostate; 2010 Dec; 70(16):1778-87. PubMed ID: 20583133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cancer/testis antigen prostate-associated gene 4 (PAGE4) is a highly intrinsically disordered protein.
    Zeng Y; He Y; Yang F; Mooney SM; Getzenberg RH; Orban J; Kulkarni P
    J Biol Chem; 2011 Apr; 286(16):13985-94. PubMed ID: 21357425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer/testis antigens trigger epithelial-mesenchymal transition and genesis of cancer stem-like cells.
    Yang P; Huo Z; Liao H; Zhou Q
    Curr Pharm Des; 2015; 21(10):1292-300. PubMed ID: 25506890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential immune-eliciting cancer testis antigens in colorectal cancer.
    Chi Soh JE; Abu N; Jamal R
    Immunotherapy; 2018 Sep; 10(12):1093-1104. PubMed ID: 30185136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-testis antigens in canine histiocytic sarcoma and other malignancies.
    Nemec PS; Kapatos A; Holmes JC; Stowe DM; Hess PR
    Vet Comp Oncol; 2019 Sep; 17(3):317-328. PubMed ID: 30854786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer/testis antigens: novel tools for discerning aggressive and non-aggressive prostate cancer.
    Shiraishi T; Getzenberg RH; Kulkarni P
    Asian J Androl; 2012 May; 14(3):400-4. PubMed ID: 22343492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of autoantibodies against cancer-testis antigens in non-small cell lung cancer.
    Djureinovic D; Dodig-Crnković T; Hellström C; Holgersson G; Bergqvist M; Mattsson JSM; Pontén F; Ståhle E; Schwenk JM; Micke P
    Lung Cancer; 2018 Nov; 125():157-163. PubMed ID: 30429015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer/testis antigens: from serology to mRNA cancer vaccine.
    Fan C; Qu H; Wang X; Sobhani N; Wang L; Liu S; Xiong W; Zeng Z; Li Y
    Semin Cancer Biol; 2021 Nov; 76():218-231. PubMed ID: 33910064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer/Testis Antigens as Targets for RNA-Based Anticancer Therapy.
    Shim K; Jo H; Jeoung D
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer.
    Nin DS; Deng LW
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cause and consequence of cancer/testis antigen activation in cancer.
    Whitehurst AW
    Annu Rev Pharmacol Toxicol; 2014; 54():251-72. PubMed ID: 24160706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer/Testis Antigens into mitochondria: a hub between spermatogenesis, tumorigenesis and mitochondrial physiology adaptation.
    Aurrière J; Goudenège D; Baris OR; Boguenet M; May-Panloup P; Lenaers G; Khiati S
    Mitochondrion; 2021 Jan; 56():73-81. PubMed ID: 33220498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer genetics/epigenetics and the X chromosome: possible new links for malignant glioma pathogenesis and immune-based therapies.
    Mintz A; Debinski W
    Crit Rev Oncog; 2000; 11(1):77-95. PubMed ID: 10795628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy.
    Gordeeva O
    Semin Cancer Biol; 2018 Dec; 53():75-89. PubMed ID: 30171980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.